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Objective. The objective of the study was to assess the relationship between selected clinical and biochemical parameters of end
stage renal disease (ESRD) patients and arterial calcification.Materials andMethods.The study comprised 59 stage 5 chronic kidney
disease patients (36 hemodialyzed and 23 predialysis). The examined parameters included common carotid artery intima-media
thickness (CCA-IMT), BMI, incidence of diabetes and impaired fasting glucose (IFG), dyslipidemia, hypertension, and 3-year
mortality. Plasma levels asymmetric dimethylarginine (ADMA), osteopontin (OPN), osteoprotegerin (OPG), and osteocalcin (OC)
were alsomeasured. Fragments of radial artery obtained during creation of hemodialysis access were stained for calcifications using
von Kossa method and alizarin red. Results.Calcification of radial artery was significantly associated with higher prevalence of IFG
and diabetes (𝑃 = 0.0004) and older age (𝑃 = 0.003), as well as higher OPG (𝑃 = 0.014) and ADMA concentrations (𝑃 = 0.022).
Fasting glucose > 5.6mmol/l (IFG and diabetes) significantly predicted vascular calcification in multiple logistic regression. The
calcification was also associated with higher CCA-IMT (𝑃 = 0.006) and mortality (𝑃 = 0.004; OR for death 5.39 [1.20–24.1]
after adjustment for dialysis status and age). Conclusion. Combination of renal insufficiency and hyperglycemic conditions exerts a
synergistic effect on vascular calcification and increases the risk of death.
1. Introduction
Vascular calcification is an active process similar to the min-
eralization that occurs in bone [1, 2]. Vascular smoothmuscle
cells undergo phenotypic differentiation into osteoblast-like
or chondroblast-like cells and they synthesize calcification
regulating proteins andmatrix components typically found in
bone and in cartilage [3, 4]. Calcification of the arterialmedia,
observed even in small vessels (Mönckeberg’s calcification), is
common in uremic patients and seems to be less associated
with inflammation as compared to intimal mineralization
typical for atherosclerosis [5, 6].
Vascular mineralization advances with age and is inten-
sified in diabetes, dyslipidemia, chronic kidney disease, and
hypertension. In newly treated hemodialysis and peritoneal
dialysis patients, diabetes, dialysis duration, and the previous
presence of aortic arch calcification (AAC) accelerate further
progression of AAC (an important risk factor for cardio-
vascular complications) [7]. Hyperinsulinemia and insulin
resistance (clinical signs of type 2 diabetes) are positively
correlatedwith the arterial calcification [8, 9]. Arterialmedial
calcifications often occur also in diabetic individuals as a
component of the diabetic macroangiopathy. In the animal
model, insulin resistance induced in rats by fructose feeding
resulted in increased aortic calcium deposition, elevated
calcium-phosphate index, and local hyperplastic changes in
the aortic media [10].
Blood vessels obtained from end stage renal disease
(ESRD) patients were often studied by various histologi-
cal techniques to assess vascular calcification. They were
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collected during renal transplantation (epigastric or iliac
arteries) or by peripheral arterial biopsy (radial artery) [3, 11,
12].
In the present study we used small samples (otherwise
routinely discarded) of radial arterial walls obtained during
creation of arteriovenous fistula for hemodialysis access. The
study was aimed at investigating the relationship between
selected clinical and biochemical parameters, with special
emphasis on diabetes markers, and the level of histologically
assessed radial artery calcification in end stage renal disease
patients.
2. Materials and Methods
2.1. Patients. The study population consisted of 59 patients
(38 males, 21 female; mean age at the beginning of the
study 61±16 yrs), including 36 onmaintenance hemodialysis
(HD) and 23 on predialysis (stage 5 of CKD). The study
was approved by the Bioethics Committee of the Jagiellonian
University and all patients signed an informed consent for
their participation. The data on mortality was collected over
a period of three years. During this period, all the patients
were treated at the Department of Nephrology, Jagiellonian
University Hospital. The mortality data, including the causes
of death, was based on the patients’ records.
2.2. Laboratory Tests. In all patients, selected biochemical
parameters were assessed: serum concentrations of total
cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides
(TG), serum creatinine, peripheral blood counts, albu-
min, glucose, intact parathyroid hormone (iPTH), total
calcium (Ca) and phosphate (Pi), high sensitive C-reactive
protein (hsCRP), asymmetric dimethylarginine (ADMA),
osteopontin (OPN), osteoprotegerin (OPG), and osteocalcin
(OC). Homeostasis Model of Assessment-Insulin Resistance
(HOMA-IR) was calculated by application of the interna-
tional formula: fasting insulin (𝜇IU/mL) × fasting glucose
(mmol/L)/22.5 [13].
Routine biochemical tests were carried out using auto-
matic biochemical analyzers: Hitachi 917 (Hitachi, Japan) and
Modular P (Roche Diagnostics, Mannheim, Germany). Con-
centrations of hsCRP were measured using immunoneph-
elometric method on Nephelometer BN II (Siemens Health-
care Diagnostics, Germany). Hematological parameters were
measured using Sysmex XE 2100 Hematological Analyzer
(Sysmex Corp., Japan).
OPN, OC, OPG, and ADMA were determined using
ELISA microplate immunoassays and ELX808 automatic
reader (BIO-TEK Instruments, Inc., Vermont, USA). The
following kits of reagents were applied: OPN (R&D Systems),
OC (METRA, Germany), OPG (QUIDEL, BioVendor, Czech
Republic), and ADMA (Immundiagnostik, Germany).
Themean arterial pressure (MAP) was calculated accord-
ing to the formula: MAP = DBP + 1/3(SBP-DBP), where SBP
is systolic blood pressure andDBP is diastolic blood pressure.
The intima-media thickness of the common carotid
artery trunk (CCA-IMT) was assessed by ultrasonography (B
presentation, Acuson 128 XP/10 apparatus equipped with a
linear head at 5/7MHz). The measurements were performed
bilaterally at 0.5 cm and 2 cm below the division of the
common carotid artery during diastolic phase of the heart
cycle. The results were expressed as the arithmetic means of
the values obtained for the left and right arteries.
2.3. Histology. Fragments of radial artery, approx. 5 × 2mm
in size, were collected during the first creation of arteri-
ovenous fistula for hemodialysis access. The samples were
immediately immersed in 10% phosphate-buffered formalin
and fixed overnight and then rinsed in PBS and soaked in
30% sucrose. The material was snap-frozen and tissue blocks
were positioned in a cryostat for cutting sections in a plane
encompassing the entire thickness of the vascular wall. Serial
10 𝜇m-thick cryosections were cut and thaw-mounted on
poly-L-lysine coated slides. Sections were stained routinely
with Mayer’s haematoxylin and eosin (HE), with von Kossa
method and with alizarin red. The stained sections were
examined using an Olympus BX-50 microscope (Olympus,
Tokyo, Japan) in brightfield mode and images were regis-
tered using Olympus DP-71 digital CCD camera controlled
by Olympus AnalySIS FIVE software. The advancement of
vascular calcification was semiquantitatively evaluated in von
Kossa and alizarin red-stained sections by two independent
observers.The degree ofmineralizationwas classified accord-
ing to the following scale: 0: no mineral content, 1: a few
small dispersed concretions, 2: numerous small dispersed
concretions, 3: larger granular concretions, and 4: large areas
occupied by fused mineral deposits. The reproducibility of
the morphological analysis was confirmed by Bland-Altman
method and by calculating intraclass correlation coefficient
(ICC) which was 0.88.
2.4. Statistical Methods. The number of patients (percentage
of the group) was reported for categorical variables and
mean ± standard deviation or median (lower-upper quartile)
for continuous variables, depending on distribution. The
Shapiro-Wilk test was used to assess normality. Contingency
tables were analyzedwith Pearson chi-squared test. Student t-
test or Mann-Whitney test was used for simple comparisons
between the groups. Multiple logistic regression models were
constructed using the variables that differed significantly
between the groups in simple comparisons and/or predefined
sets of confounders, as pointed in the results. Odds ratios
(OR) for 1 unit increase with 95% confidence intervals
(95% CI) being reported, unless otherwise stated. All tests
were two-tailed and the results were considered statistically
significant at 𝑃 ≤ 0.05. Statistica 10 software (StatSoft, Tulsa,
OK, USA) was used for computations.
3. Results
3.1. Histology. Routine histology (HE) showed general mor-
phology of the radial artery, with intimal thickening in
the vast majority of the examined specimens (Figure 1(a)).
Basophilic deposits were visible in arterial wall in cases
of very intense calcification (Figure 1(b)). The preliminary
comparison of two staining methods used for the assessment
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Figure 1: Histology of the radial artery samples. (a) Morphology of the routinely (HE) stained artery showing intimal thickening (I) and
no mineral content. I: intima; M: media; A: adventitia. (b)–(d) Serial sections of the entire sample of the arterial wall demonstrating very
advanced calcification (grade 4) stained with HE (b), von Kossa (c), and alizarin red (d). (e) Large granular calcifications (grade 3) localized
on both sides of the media (alizarin red staining). (f) Small (grade 2) calcifications in the media (alizarin red staining). ∗Lumen of the vessel.
of the mineralization degree showed that von Kossa method
was less sensitive; thus we employed alizarin red staining
for further analysis and for correlation of the vascular
calcification level with clinical and biochemical data.
Morphologically,mineral depositswere found in all layers
of the arterial wall but they were most frequently localized
in the media (Figures 1(b)–1(d)). In less advanced lesions,
deposits were preferentially located close to the outer and
inner elastic laminae (Figure 1(e)). Some deposits were fine
and dispersed (Figure 1(f)), while others occupied larger
areas and in themost advanced cases even the entire thickness
of the media (Figures 1(b)–1(d)). Only very scanty mineral
deposits were occasionally seen in the vascular intima.
Among 59 radial artery samples examined histologically,
34 showed positive alizarin red staining indicative of the
calcification process. The proportion of samples with arterial
wall mineralization (Table 1) as well as its advancement
(Figure 2(a)) did not differ between HD and predialysis
patients (𝑃 = 0.6). In further analysis, HD patients were
studied together with predialysis patients; nevertheless all
multiple regression models were adjusted for HD status.
3.2. Biochemical and Clinical Data. Table 1 summarizes dif-
ferences in clinical and biochemical parameters between the
groups with and without calcifications as assessed by alizarin
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Table 1: Differences in clinical parameters between patients with and without vascular calcifications as assessed by alizarin red staining of
the radial artery.
Patients with vascular
calcifications (grades 1–4,𝑁 = 34)
Patients without vascular
calcifications (grades 0,𝑁 = 25) 𝑃
Male gender,𝑁 (%) 23 (68%) 15 (60%) NS
HD treatment,𝑁 (%) 21 (62%) 15 (60%) NS
HD duration, monthsa 10 (3–36) 6 (1–38) NS
Hemoglobin, g/dL 10.7 ± 1.6 11.5 ± 1.9 NS
Albumin, g/L 40.3 ± 4.2 41.5 ± 6.1 NS
Age, years 66 ± 15 54 ± 14 0.003
Active smoking,𝑁 (%) 10 (29%) 7 (28%) NS
BMI, kg/m2 26.1 ± 5.6 26.4 ± 6.1 NS
Diabetes,𝑁 (%) 18 (53%) 1 (4%) <0.0001
Type 1 diabetes,𝑁 (%) 2 (6%) 0 NS
Type 2 diabetes,𝑁 (%) 16 (47%) 1 (4%) 0.0002
IFG,𝑁 (%) 3 (9%) 3 (12%) NS
SBP, mmHg 138 ± 19 146 ± 18 NS
DBP, mmHg 82 ± 9 86 ± 11 NS
MAP, mmHg 101 ± 12 106 ± 12 0.045
Fasting glucose, mmol/L 5.7 (4.9–7.9) 4.8 (4.6–5.2) 0.022
Insulin, 𝜇U/mLb 7.60 (5.85–18.89) 9.88 (6.12–13.50) NS
HOMA-IRb 1.68 (1.20–4.44) 1.89 (1.32–3.12) NS
CRP, mg/L 8.81 (2.19–24.3) 4.86 (3.06–9.82) NS
ADMA, 𝜇mol/L 0.86 ± 0.22 0.72 ± 0.16 0.022
Ca, mmol/L 2.18 ± 0.16 2.25 ± 0.27 NS
Pi, mmol/L 1.50 (1.34–1.79) 1.41 (1.21–1.86) NS
Ca × Pi, mmol2/L2 3.15 (2.88–3.77) 3.51 (2.86–3.91) NS
iPTH, pg/mL 213 (179–512) 290 (230–428) NS
OPG, pmol/L 9.36 (5.93–12.38) 5.10 (2.40–7.70) 0.014
OPN, ng/mL 310 (208–559) 304 (217–377) NS
OC, ng/mL 41.7 (31.7–69.5) 42.0 (23.9–56.0) NS
CCA-IMT, mm 0.98 ± 0.13 0.86 ± 0.14 0.006
All-cause mortality,𝑁 (%) 16 (47%) 3 (12%) 0.004
Cardiovascular mortality,𝑁 (%) 13 (38%) 3 (12%) 0.025
aData for the group of HD patients only (21 patients with calcifications and 15 patients without calcifications).
bData for nondiabetic patients only (16 patients with calcifications and 24 patients without calcifications).
red staining of radial artery. Vascular calcification was associ-
ated with higher age of patients, higher glucose, and diabetes.
MAPwas slightly lower in patients with calcifications and the
levels of ADMA and OPG were higher in this group.
Clinical criteria of the metabolic syndrome [14, 15] were
compared between patients with and without vascular cal-
cifications in radial artery (Table 2). Among patients with
vascular calcifications, the number of individuals with fasting
glucose level above 5.6mmol/L, that is, patients with IFG
(prediabetes) [16] and diabetes, was significantly higher (𝑃 =
0.0004). Moreover, vascular calcifications were more severe
in the group of patients with IFG and diabetes (Figure 2(b)).
Other criteria of the metabolic syndrome did not differ
between the groups with or without calcifications.
The association of radial artery calcifications with IFG
and diabetes was further confirmed by multiple logistic
regression (Table 3). Three models were constructed, con-
taining age and fasting glucose > 5.6mmol/L as independent
variables: the first onewas adjusted for gender,HD status, and
Ca × Pi product, and the second was additionally adjusted
for dyslipidemia, hypertension, high BMI, and hsCRP. The
thirdmodel, adjusted as the first one, included other variables
that were significantly associated with arterial calcification in
simple comparisons, that is, MAP, ADMA, and OPG. Fasting
glucose > 5.6mmol/L was the only variable independently
associated with the vascular calcifications in all three models.
The results were similar when diabetes was substituted for
increased fasting glucose level in the models: OR = 17.2 (1.79–
166); 𝑃 = 0.011 in model 1; OR = 25.4 (1.74–372); 𝑃 = 0.015
in model 2; OR = 24.6 (1.45–419); 𝑃 = 0.022 in model 3.
Patients with calcifications in radial arteries presented
higher CCA-IMT (Table 1). The relation between CCA-IMT
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Figure 2: Advancement of vascular calcification as assessed by alizarin red staining in radial arteries: 0: no mineral deposits in arterial wall,
1-2: mild calcification, and 3-4: advanced calcification. (a) Calcification in predialysis patients versus HD patients (𝑃 = 0.6 in chi-squared
test). (b) Calcification in patients with normal fasting glucose (<5.6mmol/L) versus IFG (prediabetes) or diabetes (𝑃 = 0.002 in chi-squared
test; 𝑃 = 0.004 (∗∗) and 𝑃 = 0.03 (∗) in post hoc tests). IFG: impaired fasting glucose.
and histologically detected vascular calcification remained
significant after adjustment for dialysis status, gender, Ca ×
Pi, hsCRP, and the presence of metabolic syndrome (OR for
vascular calcification 2.31 per 0.1mm increase in CCA-IMT;
95%CI 1.18–4.52; 𝑃 = 0.011) but not after adjustment for age.
CCA-IMT was significantly higher in patients with IFG and
diabetes (0.98 ± 0.13 versus 0.88 ± 0.15mm; 𝑃 = 0.007).
Sixteen patients with calcifications in the radial artery
(47%) died during 3 years of the followup, while in the group
without calcifications themortality was lower: 3 deaths (12%).
All except 3 deaths occurred due to cardiovascular causes
(Table 1). Vascular calcification was significantly associated
with patients’ mortality in simple analysis (𝑃 = 0.004) and
after adjustment for HD status and age (OR for death 5.39;
95%CI 1.20–24.1; 𝑃 = 0.024).
4. Discussion
This study presents a comprehensive comparison of biochem-
ical and clinical data with the calcification status assessed
histologically in the peripheral arteries of ESRD patients.
Biopsies of radial artery collected during the creation of
vascular access for hemodialysis were used previously by
other authors to study calcification. However, in that study,
the surgical anastomosis was performed in an end-to-end
fashion; thus a sample encompassing the entire circumfer-
ence of the artery could be excised and used for further
analysis, allowing for a more reliable assessment of the
calcification extent in the arterial wall [12].
In the study mentioned above, the authors found mineral
deposits in 37% of the examined radial arteries. After adopt-
ing stringentmorphological criteria to include even the finest
calcifications and using more sensitive alizarin red staining
for calcium detection we found arterial calcification in 57%
of cases.
Calcification can develop in two distinct layers of the
artery: intima and media [17]. Intimal calcification occurs
in advanced atherosclerotic lesions and is associated with
lipid accumulation and infiltration of the inflammatory cells,
such as macrophages and T cells. Medial arterial calcification
(MAC) displays features very similar to those of physiological
calcification in bone [18]. MAC develops independently of
atherosclerosis and is a commonly observed pathology in
diabetes, ESRD, and ageing [17].
The present study revealed a significant association of
arterial medial calcifications with impaired fasting glucose
(IFG, prediabetes) and diabetes but not with other crite-
ria of the metabolic syndrome including overweight. Our
results are in accordance with the study of Lim et al.
[19] demonstrating the relationship between anthropometric
parameters, metabolic profiles, and coronary artery calcium
scoring (CACS). Subjects with IFG or diabetes had higher
CACS and more advanced coronary stenosis than normal
subjects. Moreover, several studies confirmed that fasting
plasma glucose is a better independent determinant of the
progression of coronary artery calcification than the other
metabolic syndrome risk factors [20–22].
The above mentioned papers presented a relationship
between hyperglycemia and vascular calcification based on
noninvasive imaging of blood vessels. In our study, this rela-
tionship was analyzed for the first time using histologically
examined samples of peripheral arteries.
Hyperglycemia is an established risk factor for cardiovas-
cular disease. Our study showed that fasting hyperglycemia,
mostly associated with type 2 diabetes, was the only signif-
icant predictor of vascular calcifications in ESRD patients.
Consistently, type 2 diabetes was associated with more severe
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Table 2: Differences in clinical criteria of the metabolic syndrome between patients with and without vascular calcifications as assessed by
alizarin red staining of the radial artery.
Patients with vascular
calcifications (grades 1–4,𝑁 = 34)
Patients without vascular
calcifications (grades 0,𝑁 = 25) 𝑃
BMI > 25 kg/m2 (overweight or obesity),𝑁 (%) 18 (53%) 14 (56%) NS
Fasting glucose > 5.6mmol/L (IFG or diabetes),𝑁 (%) 21 (62%) 4 (16%) 0.0004
Hypertension,𝑁 (%) 28 (82%) 23 (92%) NS
Low HDLa,𝑁 (%) 13 (38%) 7 (28%) NS
High TG (>1.7mmol/L),𝑁 (%) 15 (44%) 12 (48%) NS
Three or more of above criteria present,𝑁 (%) 20 (59%) 9 (36%) NS
aLow HDL cholesterol (<1.0mmol/L in men, <1.3mmol/L in women).
Table 3: Multiple logistic regression models to study the associations of the selected variables with vascular calcifications as assessed by
alizarin red staining of the radial artery.
Model 1a Model 2b Model 3a
OR (95% CI) 𝑃 OR (95% CI) 𝑃 OR (95% CI) 𝑃
Age, years 1.05 (0.99–1.10) NS 1.05 (0.99–1.11) NS 1.00 (0.93–1.08) NS
Fasting glucose > 5.6mmol/Lc 8.24 (1.66–40.9) 0.008 14.8 (1.68–130) 0.012 23.8 (1.84–309) 0.012
MAP, mmHg — — — — 0.93 (0.86–1.02) NS
ADMA, 0.1 𝜇mol/L — — — — 1.66 (0.70–3.92) NS
OPG, pmol/L — — — — 1.16 (0.92–1.45) NS
Odds ratios for positive staining are presented.
aAdjusted for gender, dialysis status of patients, and Ca × Pi.
bAdjusted for the parameters of themetabolic syndrome: lowHDL cholesterol (<1.0mmol/L inmen,<1.3mmol/L inwomen), high triglycerides (>1.7mmol/L),
and high BMI (≥25 kg/m2), as well as hypertension, CRP, gender, dialysis status of patients, and Ca × Pi.
cIncludes patients with IFG and patients with diabetes.
Bold font: statically significant data.
calcification. Recent evidence suggests that medial calcifica-
tion in diabetes is an active, cell-mediated process, similar to
that observed in patients with end stage renal disease [23, 24].
Vascular calcifications and atherosclerosis are frequent in
patients with ESRD and they are associated with increased
cardiovascular morbidity [25]. Coronary artery calcification
(CAC) was found in 70.2% of dialysis patients and was
significantly associated with CCA-IMT and the thickness of
atherosclerotic plaques [26]. These results indicate that both,
medial calcification and atherosclerotic lesions, frequently
coexist in patients with ESRD and that CCA-IMT, increased
in patients with calcifications examined in this study, may
serve as a surrogate marker of vascular calcification.
The mechanisms responsible for vascular calcification
include inflammation and oxidative stress, as well as bone
and mineral metabolism disturbances. In our study higher
ADMA and OPG levels were associated with vascular calci-
fication. High ADMA levels are associated with endothelial
dysfunction and cardiovascular damage [27]. Serum levels of
ADMA in chronic kidney disease increase due to its defective
inactivation and excretion. Coen at al. [28] postulated that
ADMAmay play a role in the pathogenesis of vascular calcifi-
cation in dialysis patients. Increased serumOPG is associated
with type 2 diabetes, chronic kidney disease, and the severity
of vascular calcification and coronary artery disease [29–31].
It could represent a compensatory mechanism for vascular
damage, also showing a protective effect against vascular
calcification [32, 33].
Arterial calcification was associated with higher mor-
tality in ESRD patients. According to our knowledge, the
relationship between vascular calcification assessed histolog-
ically and the long-term mortality in chronic kidney disease
patients has not yet been studied. Ogawa et al. [34] examined
the effect of CT-assessed aortic arch calcification onmortality
in the 401 hemodialysis patients during 4-year follow-up
period and demonstrated that cardiovascular mortality was
significantly higher in patientswith calcification. In our study,
employing a different assessment model (radial artery and
histology) this effect of arterial calcification on mortality in
ESRD patients has been confirmed.
5. Conclusions
Small samples of radial artery obtained during creation
of vascular access for hemodialysis may successfully serve
as source of the material for histological assessment of
vascular mineralization. In end stage renal disease patients,
impaired fasting glucose (prediabetes) and diabetes predict
vascular calcification which is significantly associated with
higher mortality. These results indicate that combination of
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renal insufficiency and hyperglycemic conditions exerts a
synergistic effect on vascular calcification and increases the
risk of death.
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